Browsing by Yonsei Author : Park, Ki Cheong

Name:
Park, Ki Cheong [박기청] http://orcid.org/0000-0002-3435-3985
Department :
College of Medicine (의과대학) - Dept. of Surgery (외과학교실)
Y-HRN :
(Yonsei Health Research Network)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2020Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer CANCERS
2020Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
2019VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis BMC Cancer
2019Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer Translational Oncology
2018Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype Nature Communications
2018SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with altnernating Sorafenib and Lenvatinib for refractory thyroid cancer BMC CANCER
2018Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophagesAMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
2018Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase ExpressionCLINICAL CANCER RESEARCH
2018Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells NEOPLASIA
2017Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer NEOPLASIA
2015Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway ONCOTARGET
2015Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer. BMC CANCER
2015The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells BMC CANCER
2015The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells BMC CANCER
2014A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells BRITISH JOURNAL OF PHARMACOLOGY
2013Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancerCELLULAR ONCOLOGY
2013Effects of endostatin and a new drug terpestacin against human neuroblastoma xenograft and cell linesPEDIATRIC SURGERY INTERNATIONAL
2011Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivoCANCER SCIENCE
2010Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing JOURNAL OF BIOLOGICAL CHEMISTRY
2008Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ductsHEPATOLOGY RESEARCH
2006Accumulation of β-catenin protein, mutations in exon-3 of the β-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreasJOURNAL OF SURGICAL ONCOLOGY
1

Browse

Links